Biome expects first month of positive EBITDA in FY24
Filed with ASX · · 3 pages · English
Watch Biome Australia's latest callBiome Australia (ASX:BIO) Q1 2026 Earnings Call · Replay · Oct 22, 2025Read the transcript of Biome Australia (ASX:BIO) Q1 2026 Earnings CallEarlier from Biome Australia
- Biome Lift Clinical Trial Presentation
- Biome Lift trial update positive results received
- Full year revenue guidance FY23
- Biome secures $1.2 million revolving debt facility
- Biome surpasses $7m sales revenue target
Later from Biome Australia
- Revenue Update
- Biome signs landmark agreement to develop IP
- Biome to launch cholesterol reducing probiotic
- Biome Achieves Record Quarter and Half Year Sales
- FY24 Revenue Guidance Upgrade to $12.5M
Follow Biome Australia into a list and get an email when it puts out news.
Follow Biome Australia